0001225208-14-006514.txt : 20140226 0001225208-14-006514.hdr.sgml : 20140226 20140226205138 ACCESSION NUMBER: 0001225208-14-006514 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140224 FILED AS OF DATE: 20140226 DATE AS OF CHANGE: 20140226 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE BOSTON SCIENTIFIC PL CITY: NATICK STATE: MA ZIP: 01760-1537 BUSINESS PHONE: 508-650-8000 MAIL ADDRESS: STREET 1: ONE BOSTON SCIENTIFIC PL CITY: NATICK STATE: MA ZIP: 01760-1537 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dawkins Keith D CENTRAL INDEX KEY: 0001492253 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11083 FILM NUMBER: 14646491 MAIL ADDRESS: STREET 1: BOSTON SCIENTIFIC CORPORATION STREET 2: ONE BOSTON SCIENTIFIC PLACE CITY: NATICK STATE: MA ZIP: 01760 4 1 doc4.xml X0306 4 2014-02-24 0000885725 BOSTON SCIENTIFIC CORP BSX 0001492253 Dawkins Keith D ONE BOSTON SCIENTIFIC PLACE NATICK MA 01760-1537 1 EVP, Global Chief Med. Off. Common Stock 2014-02-24 4 A 0 36441.0000 0.0000 A 120398.0000 D Common Stock 2014-02-24 4 M 0 2408.0000 0.0000 A 122806.0000 D Common Stock 2014-02-24 4 F 0 12633.0000 13.0800 D 110173.0000 D Deferred Stock Units 2014-02-24 4 M 0 2408.0000 0.0000 D Common Stock 2408.0000 68789.0000 D Deferred Stock Units 2014-02-24 4 A 0 11467.0000 0.0000 A 2019-02-24 Common Stock 11467.0000 11467.0000 D Performance Share Units 2014-02-24 4 A 0 24011.0000 0.0000 A 2015-12-31 2015-12-31 Common Stock 24011.0000 24011.0000 D Stock Option (Right to Buy) 13.0800 2014-02-24 4 A 0 27322.0000 0.0000 A 2024-02-24 Common Stock 27322.0000 27322.0000 D On February 28, 2011, the reporting person was awarded a target number of performance share units under the Company's 2011 Total Shareholder Return Performance Share Program, the actual number of which to be earned by the reporting person was based on the Company's total shareholder return performance percentile relative to that of the other companies in the S&P 500 Healthcare Index over the three annual performance cycles comprising the three-year period ended December 31, 2013 and was subject to the completion of the concurrent three-year individual service period. On February 24, 2014, the number of the target performance share units as to which the performance criteria had been satisfied was determined and the individual service period was satisfied. Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 24, 2010, the first anniversary of the date of grant. Reflects multiple DSU awards with independent vesting schedules. Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant. Each performance share unit represents the Company's commitment to issue one share of Boston Scientific common stock. On February 28, 2013, the reporting person was awarded a target number of performance share units under the Company's 2013 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2013 adjusted free cash flow measured against its 2013 financial plan over the one-year performance period ending December 31, 2013 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 24, 2014, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined will vest in whole on December 31, 2015 upon the completion of the individual service period. Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant. /s/ Lee G. Giguere, Attorney-in-Fact 2014-02-26